Lotus Pharmaceutical Co., Ltd.

Lotus Pharmaceutical (TWSE: 1795), founded in 1966 and part of the Alvogen organization, is one of Asia's largest specialty pharma companies with 250+ commercial products in 90+ markets. Focused on oncology, cardiology, nephrology, and CNS, with USFDA, EMA, and PMDA approved facilities including cytotoxic and high-potency drug manufacturing. Offers CDMO services, including to global partners like Boryung (Korea).